Aminocaproic acid is used for the prevention and treatment of bleeding caused by hyperfibrinolysis; it acts as an antifibrinolytic agent by inhibiting the binding of plasminogen to fibrin, thereby preventing its activation to plasmin and subsequent fibrinolysis; at high concentrations (100 mg/L), it directly inhibits plasmin activity, achieving hemostatic effects.